The global IVitro diagnostics market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases and rising demand for personalized medicine. The market is also driven by factors such as increasing number of research and development activities in the field of IVitro diagnostics, growing awareness about the benefits offered by IVitro diagnostics, and technological advancements in this field.
The global IVitro diagnostics market has been segmented on the basis of type into tissue diagnostics, professional diagnostic, molecular diagnostic, diabetes monitoring; on the basis of application into diabetes, infectious diseases, oncology (cancer), cardiology (heart), HIV; and on the basis of region into North America (NA), Latin America (LA), Europe (EU), Asia Pacific & Middle East & Africa (APMEA).
-The global market for in-vitro diagnostics is expected to grow at a CAGR of 5.2% from 2016 to 2020. -In the US, the market size for in vitro diagnostics was $6 billion in 2015 and is projected to reach $8 billion by 2020, growing at a CAGR of 4%.
-In the US, the market size for in vitro diagnostics was $6 billion in 2015 and is projected to reach $8 billion by 2020, growing at a CAGR of 4%. -The growth factors are due mainly due to an increase in demand for personalized medicine and an aging population that will require more diagnostic testing as they age.
Industry Growth Insights published a new data on “In-Vitro Diagnostics Market”. The research report is titled “In-Vitro Diagnostics Market research by Types (Tissue diagnostics, Professional diagnostic, Molecular diagnostic, Diabetes Monitoring), By Applications (Diabetes, Infectious Diseases, Oncology, Cardiology, HIV, Other), By Players/Companies Siemens Healthcare, Johnson and Johnson, Becton Dickinson, Abbott Laboratories, Roche Diagnostics, Beckman Coulter Inc, Thermo Scientific, Cobas, Caprion, Merck Millipore, Aptiv Solution, Danaher Corporation, Biomerieux, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Sysmex Corporation, Mindray, Shanghai Kehua Bio-engineering, BioSino Bio-technology, Beijing Leadman Biochemistry, DAAN Gene”.
Scope Of The Report
Report Attributes
Report Details
Report Title
In-Vitro Diagnostics Market Research Report
By Type
Tissue diagnostics, Professional diagnostic, Molecular diagnostic, Diabetes Monitoring
By Application
Diabetes, Infectious Diseases, Oncology, Cardiology, HIV, Other
By Companies
Siemens Healthcare, Johnson and Johnson, Becton Dickinson, Abbott Laboratories, Roche Diagnostics, Beckman Coulter Inc, Thermo Scientific, Cobas, Caprion, Merck Millipore, Aptiv Solution, Danaher Corporation, Biomerieux, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Sysmex Corporation, Mindray, Shanghai Kehua Bio-engineering, BioSino Bio-technology, Beijing Leadman Biochemistry, DAAN Gene
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global In-Vitro Diagnostics Market Report Segments:
The global In-Vitro Diagnostics market is segmented on the basis of:
Types
Tissue diagnostics, Professional diagnostic, Molecular diagnostic, Diabetes Monitoring
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diabetes, Infectious Diseases, Oncology, Cardiology, HIV, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens Healthcare
- Johnson and Johnson
- Becton Dickinson
- Abbott Laboratories
- Roche Diagnostics
- Beckman Coulter Inc
- Thermo Scientific
- Cobas
- Caprion
- Merck Millipore
- Aptiv Solution
- Danaher Corporation
- Biomerieux
- Bio-Rad Laboratories
- Ortho Clinical Diagnostics
- Sysmex Corporation
- Mindray
- Shanghai Kehua Bio-engineering
- BioSino Bio-technology
- Beijing Leadman Biochemistry
- DAAN Gene
Highlights of The In-Vitro Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tissue diagnostics
- Professional diagnostic
- Molecular diagnostic
- Diabetes Monitoring
- By Application:
- Diabetes
- Infectious Diseases
- Oncology
- Cardiology
- HIV
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the In-Vitro Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
In-Vitro Diagnostics is a company that provides diagnostic services for the medical industry. It offers a variety of tests, including those used to diagnose cancer and other diseases. In-Vitro Diagnostics also provides consulting services to hospitals and other medical providers.
Some of the major players in the in-vitro diagnostics market are Siemens Healthcare, Johnson and Johnson, Becton Dickinson, Abbott Laboratories, Roche Diagnostics, Beckman Coulter Inc, Thermo Scientific, Cobas, Caprion, Merck Millipore, Aptiv Solution, Danaher Corporation, Biomerieux, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Sysmex Corporation, Mindray, Shanghai Kehua Bio-engineering, BioSino Bio-technology, Beijing Leadman Biochemistry, DAAN Gene.
The in-vitro diagnostics market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. In-Vitro Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. In-Vitro Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. In-Vitro Diagnostics Market - Supply Chain
4.5. Global In-Vitro Diagnostics Market Forecast
4.5.1. In-Vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. In-Vitro Diagnostics Market Size (000 Units) and Y-o-Y Growth
4.5.3. In-Vitro Diagnostics Market Absolute $ Opportunity
5. Global In-Vitro Diagnostics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. In-Vitro Diagnostics Market Size and Volume Forecast by Type
5.3.1. Tissue diagnostics
5.3.2. Professional diagnostic
5.3.3. Molecular diagnostic
5.3.4. Diabetes Monitoring
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global In-Vitro Diagnostics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. In-Vitro Diagnostics Market Size and Volume Forecast by Application
6.3.1. Diabetes
6.3.2. Infectious Diseases
6.3.3. Oncology
6.3.4. Cardiology
6.3.5. HIV
6.3.6. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global In-Vitro Diagnostics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. In-Vitro Diagnostics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global In-Vitro Diagnostics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. In-Vitro Diagnostics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global In-Vitro Diagnostics Demand Share Forecast, 2019-2026
9. North America In-Vitro Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America In-Vitro Diagnostics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America In-Vitro Diagnostics Market Size and Volume Forecast by Application
9.4.1. Diabetes
9.4.2. Infectious Diseases
9.4.3. Oncology
9.4.4. Cardiology
9.4.5. HIV
9.4.6. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America In-Vitro Diagnostics Market Size and Volume Forecast by Type
9.7.1. Tissue diagnostics
9.7.2. Professional diagnostic
9.7.3. Molecular diagnostic
9.7.4. Diabetes Monitoring
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America In-Vitro Diagnostics Demand Share Forecast, 2019-2026
10. Latin America In-Vitro Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America In-Vitro Diagnostics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America In-Vitro Diagnostics Market Size and Volume Forecast by Application
10.4.1. Diabetes
10.4.2. Infectious Diseases
10.4.3. Oncology
10.4.4. Cardiology
10.4.5. HIV
10.4.6. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America In-Vitro Diagnostics Market Size and Volume Forecast by Type
10.7.1. Tissue diagnostics
10.7.2. Professional diagnostic
10.7.3. Molecular diagnostic
10.7.4. Diabetes Monitoring
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America In-Vitro Diagnostics Demand Share Forecast, 2019-2026
11. Europe In-Vitro Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe In-Vitro Diagnostics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe In-Vitro Diagnostics Market Size and Volume Forecast by Application
11.4.1. Diabetes
11.4.2. Infectious Diseases
11.4.3. Oncology
11.4.4. Cardiology
11.4.5. HIV
11.4.6. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe In-Vitro Diagnostics Market Size and Volume Forecast by Type
11.7.1. Tissue diagnostics
11.7.2. Professional diagnostic
11.7.3. Molecular diagnostic
11.7.4. Diabetes Monitoring
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe In-Vitro Diagnostics Demand Share, 2019-2026
12. Asia Pacific In-Vitro Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific In-Vitro Diagnostics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific In-Vitro Diagnostics Market Size and Volume Forecast by Application
12.4.1. Diabetes
12.4.2. Infectious Diseases
12.4.3. Oncology
12.4.4. Cardiology
12.4.5. HIV
12.4.6. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific In-Vitro Diagnostics Market Size and Volume Forecast by Type
12.7.1. Tissue diagnostics
12.7.2. Professional diagnostic
12.7.3. Molecular diagnostic
12.7.4. Diabetes Monitoring
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific In-Vitro Diagnostics Demand Share, 2019-2026
13. Middle East & Africa In-Vitro Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa In-Vitro Diagnostics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa In-Vitro Diagnostics Market Size and Volume Forecast by Application
13.4.1. Diabetes
13.4.2. Infectious Diseases
13.4.3. Oncology
13.4.4. Cardiology
13.4.5. HIV
13.4.6. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa In-Vitro Diagnostics Market Size and Volume Forecast by Type
13.7.1. Tissue diagnostics
13.7.2. Professional diagnostic
13.7.3. Molecular diagnostic
13.7.4. Diabetes Monitoring
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa In-Vitro Diagnostics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global In-Vitro Diagnostics Market: Market Share Analysis
14.2. In-Vitro Diagnostics Distributors and Customers
14.3. In-Vitro Diagnostics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Siemens Healthcare
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Johnson and Johnson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Becton Dickinson
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Abbott Laboratories
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Roche Diagnostics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Beckman Coulter Inc
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Thermo Scientific
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Cobas
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Caprion
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Merck Millipore
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Aptiv Solution
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Danaher Corporation
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Biomerieux
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Bio-Rad Laboratories
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Ortho Clinical Diagnostics
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Sysmex Corporation
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Mindray
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Shanghai Kehua Bio-engineering
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. BioSino Bio-technology
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Beijing Leadman Biochemistry
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
